Therapeutics
See the pages linked below.
Related pages
- ACE inhibitors in heart failure
- Alcohol and coronary heart disease
- Alpha blockers in hypertension
- Angioplasty and atherosclerotic renal artery stenosis
- Anti-hypertensive therapy and risk of type II diabetes
- Aspirin in atrial fibrillation
- Beta blockers in cardiac failure
- Beta-blockers in myocardial infarction
- Bypass grafting versus medical treatment in angina
- Evidence comparing CABG and coronary angioplasty
- Calcium channel blockers in myocardial infarction
- Captopril Prevention Project
- CAPRIE trial
- CURE trial
- Digoxin in heart failure - trial evidence
- Cholesterol-lowering therapy
- Heart Outcomes Prevention Evaluation Study
- HOPE study in diabetics
- IONA study (Impact Of Nicorandil in Angina)
- INSIGHT trial
- Hypertension Optimal Treatment study
- LIFE study
- N-BNP levels to guide heart failure treatment
- NORDIL study
- PARADIGM-HF - angiotensin receptor neprilysin inhibition (ARNI) versus enalapril in reduced ejection fraction heart failure (HFrEF)
- Prevention of thromboembolism in atrial fibrillation
- Primary prevention of stroke in atrial fibrillation
- Secondary prevention of stroke in atrial fibrillation
- RALES study
- SYST-EUR study
- Therapeutic trials in congestive heart failure
- Treating hypertension to prevent stroke
- Trials of therapeutic intervention in MI
- Trials related to ACE inhibitors in cardiac failure
- Trials with respect to treatment of hypercholesterolaemia
- Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Study
- Valsartan Anti-hypertensive Long-term Use Evaluation (VALUE)
- Prasugrel or ticagrelor in ACS (acute coronary syndrome) - comparative evidence
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF)
- Bedtime versus morning ingestion of hypertension and cardiovascular (CV) risk
- COLchicine Cardiovascular Outcomes Trial (COLCOT) - Efficacy and Safety of low-dose colchicine after myocardial infarction
- The Blood Pressure Lowering Treatment Trialists' Collaboration meta-analysis - pharmacological blood pressure lowering for prevention of cardiovascular disease
- AUGUSTUS trial - antithrombotic therapy after acute coronary syndrome (ACS) or PCI (percutaneous intervention) in atrial fibrillation (AF)
- Low-dose triple-pill vs standard-care protocols for hypertension treatment in Nigeria
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page